Valley National Advisers’s Avanos Medical AVNS Stock Holding History

Valley National Advisers’s Portfolio AVNS Stock Details AVNS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-2,500	Closed	-$87K	–	910
2021 Q4	$87K	Hold	2,500	–	–	0.02%	300
2021 Q3	$78K	Hold	2,500	–	–	0.01%	304
2021 Q2	$91K	Hold	2,500	–	–	0.02%	290
2021 Q1	$109K	Hold	2,500	–	–	0.02%	265
2020 Q4	$115K	Hold	2,500	–	–	0.02%	241
2020 Q3	$83K	Hold	2,500	–	–	0.02%	247
2020 Q2	$73K	Hold	2,500	–	–	0.02%	252
2020 Q1	$67K	Buy	+2,500	New	+$74.7K	0.02%	253
2019 Q4	–	Sell	-1,000	Closed	-$37K	–	750
2019 Q3	$37K	Buy	+1,000	New	+$38.1K	0.01%	341
2016 Q4	–	Sell	-2	Closed	–	–	638
2016 Q3	$0	Hold	2	–	–	﹤0.01%	639
2016 Q2	$0	Hold	2	–	–	﹤0.01%	610
2016 Q1	$0	Hold	2	–	–	﹤0.01%	592
2015 Q4	$0	Hold	2	–	–	﹤0.01%	592
2015 Q3	$0	Hold	2	–	–	﹤0.01%	604
2015 Q2	$0	Sell	2 -107	-98%	-$4.8K	﹤0.01%	607
2015 Q1	$5K	Buy	+109	New	+$5.05K	﹤0.01%	435

Other funds holding AVNS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

RGM Capital Naples, Florida $2.06B AUM 8.49% 1-Year Est. Return

PIM

Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

WHG

Westwood Holdings Group Dallas, Texas $13.7B AUM 21.48% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Valley National Advisers's AVNS Position: Q1 2022 in Review

Valley National Advisers sold out of Avanos Medical (AVNS) in Q1 2022, closing a stake of 2,500 shares — an estimated $87K sold.

Valley National Advisers first reported a position in AVNS in Q1 2015 and held it in 16 quarters. The position peaked at $115K in Q4 2020. 299 funds tracked by Wall St. Rank hold AVNS as of Q1 2022.

Valley National Advisers reported no remaining Avanos Medical position as of Q1 2022 after selling out during the quarter.
Valley National Advisers sold 2,500 Avanos Medical shares in Q1 2022, an estimated $87K.
Valley National Advisers first reported a position in Avanos Medical in Q1 2015 and held it in 16 quarters.
Valley National Advisers's Avanos Medical position peaked at $115K in Q4 2020.
299 funds tracked by Wall St. Rank held Avanos Medical as of Q1 2022.

Based on Valley National Advisers's 13F filing for Q1 2022, filed 6 May 2022.